Trinity Biotech Plc ADR (TRIB) concluded trading on Wednesday at a closing price of $0.59, with 22.59 million shares of worth about $13.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.90% during that period and on Wednesday, January 31 the price saw a gain of about 35.66%. Currently the company’s common shares owned by public are about 38.11M shares, out of which, 35.71M shares are available for trading.
Stock saw a price change of 43.90% in past 5 days and over the past one month there was a price change of 37.53%. Year-to-date (YTD), TRIB shares are showing a performance of 37.53% which decreased to -46.84% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.37 but also hit the highest price of $1.24 during that period. The average intraday trading volume for Trinity Biotech Plc ADR shares is 49.36K. The stock is currently trading 30.29% above its 20-day simple moving average (SMA20), while that difference is up 30.26% for SMA50 and it goes to -17.95% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Trinity Biotech Plc ADR (NASDAQ: TRIB) currently have 38.11M outstanding shares and institutions hold larger chunk of about 16.05% of that.
The stock has a current market capitalization of $22.54M and its 3Y-monthly beta is at 1.30. It has posted earnings per share of -$0.75 in the same period. It has Quick Ratio of 1.80. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TRIB, volatility over the week remained 12.23% while standing at 12.50% over the month.
Analysts are in expectations that Trinity Biotech Plc ADR (TRIB) stock would likely to be making an EPS of -$0.15 in the current quarter, while forecast for next quarter EPS is -$0.14 and it is -$0.3 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.15 which is -$0.15 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.23 in the same quarter a year ago. EPS is likely to grow at an annualized rate of 15.00% for next 5-years, compared to annual growth of 8.35% made by the stock over the past 5-years.
